Manuel Litchman MD insider trades
Open-market stock purchases and sales by Manuel Litchman MD, President, CEO and Interim CFO at Mustang BIO, Inc, from SEC Form 4 filings since Nov 20, 2018.
Track record: 0% of 14 scored buys are up 5% or more since purchase, averaging -81%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 24, 2026 | MBIO Mustang BIO, Inc | Sold (not open market) | $14 |
Companies traded
- MBIO Mustang BIO, Inc: 14 buys, 2 sales, last Apr 24, 2026